Introduction The pharmaceutical industry currently faces a monumental challenge in the form of stagnant research and development productivity, where the time and capital required to bring a new drug to market have reached unprecedented levels. Says Andrew Hillman, traditional computational methods, while powerful, often struggle to simulate the complex quantum mechanical interactions of molecular systems with […]